ProCE Banner Activity

Major Discoveries and the Prospect of Improved Patient Survival in AML and ALL

Clinical Thought
Here is an overview of some new approaches for the treatment of AML and ALL that are showing promise in clinical trials.

Released: July 26, 2016

Expiration: July 25, 2017

Share

Faculty

Farhad Ravandi

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by an educational donation from

Amgen, Inc.

Faculty Disclosure

Primary Author

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Farhad Ravandi, MD, has disclosed that he has received consulting fees from Amgen, Karyopharm, Seattle Genetics, and Sunesis and funds for research support from Amgen, Seattle Genetics, Sunesis, and Xencor.